GSK completes $95m investment for continuous manufacturing in Singapore
GSK opens two continuous manufacturing facilities and expands an existing production building to shorten timelines in the production of daprodustat.
GSK opens two continuous manufacturing facilities and expands an existing production building to shorten timelines in the production of daprodustat.
Cipla teams up with Acebright to create joint venture, which will involve the building of a manufacturing facility to produce respiratory products.
Indian’s pharma industry has a growing interest in the Chinese market, as regulatory changes ease entry onto the second largest market in the world.
Biopharmaceutical companies are increasingly relying on CROs in Japan, says an executive with PRA, which recently established a new subsidiary in the country.
Massive Bio is looking to create the world’s largest AI-enabled ‘just-in-time’ oncology site network to accelerate study recruitment – and believes that 15-20% of advanced-stage cancer patients can be enrolled in clinical trials, says CEO.
Product Specific PTRS, Evaluate’s machine learning platform, aims to help assess the likelihood of a drug reaching the market – managing the risks of drug development.
Analytical solutions provider, Cytel, launches its East On Demand system to provide small biotechs access to more flexible software for adaptive trial design.
Takeda and Sosei both have a proud heritage in Japan and recently entered a billion-dollar partnership with Sosei to discover, develop, and commercialize molecules for patients in need around the world.
TrialScout, a clinical trials ratings and review platform, recently announced its first Excellence in Clinical Research Top 50 Hospitals award.
It’s a lot more complicated than a simple technology – says Iqvia global head of virtual trials, who shares four lessons learned during a discussion at the company’s headquarters in Research Triangle Park.
Jubilant voluntarily recalls one lot of contraceptive tablets due to out-of-specification dissolution results, potentially decreasing efficacy.
ACG Engineering acquires Xertecs to add European design to its existing Indian engineering and manufacturing capabilities as it globalizes.
Croda plans investments in life science business after high-purity excipient delivery system business drives 24% jump in healthcare sales.